Sign in

Roivant Sciences Ltd.

Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19
Total revenue 0.01 0.03 0.03 0.03 0.06 0.02 0.07 0.00
Cost of revenue 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00
Gross profit 0.01 0.03 0.03 0.03 0.05 0.02 0.07 0.00
Total operating expenses + 1.29 1.14 0.86 0.84 1.26 1.09 0.60 0.75
Operating income -1.29 -1.11 -0.82 -0.81 -1.21 -1.07 -0.53 -0.75
Non-operating income (net) 1.02 0.43 5.39 -0.08 0.29 0.17 -0.03 -0.06
Income before tax -0.26 -0.68 4.57 -0.88 -0.92 -0.90 -0.56 -0.81
Income tax expense 0.13 0.05 0.02 0.00 0.00 0.00 0.01 0.00
Net income -0.30 -0.17 4.35 -1.01 -0.85 -0.81 1.20 -1.04
Show Quarterly Income Statement
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20
Total revenue 0.00 0.00 0.00 0.00 0.01 0.01 0.00 0.00 0.03 0.02 0.00 0.02 0.03 0.02 0.01 0.00 0.01 0.02 0.01 0.01 0.02 0.01 0.00 0.00
Cost of revenue 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00
Gross profit 0.00 0.00 0.00 0.00 0.01 0.01 0.00 0.00 0.02 0.02 0.00 0.02 0.02 0.01 0.01 0.00 0.01 0.02 0.01 0.01 0.01 0.01 0.00 0.00
Total operating expenses + 0.36 0.34 0.31 0.29 0.29 0.28 0.35 0.35 0.29 -5.11 0.22 0.29 0.25 0.29 0.29 0.28 0.27 0.27 0.69 0.16 -0.04 0.26 0.16 0.12
Operating income -0.35 -0.34 -0.31 -0.28 -0.28 -0.27 -0.34 -0.34 -0.27 5.13 -0.21 -0.28 -0.23 -0.28 -0.28 -0.28 -0.27 -0.25 -0.68 -0.15 -0.54 -0.26 -0.16 -0.11
Non-operating income (net) 0.81 0.05 0.15 0.02 0.08 0.04 0.12 0.12 0.07 0.03 -0.03 -0.05 0.05 -0.10 -0.03 -0.07 -0.03 -0.06 0.46 0.05 -0.02 -0.02 0.10 0.11 0.00
Income before tax 0.45 -0.29 -0.16 -0.27 -0.20 -0.23 -0.22 -0.22 -0.19 5.15 -0.24 -0.33 -0.18 -0.38 -0.31 -0.35 -0.29 -0.31 -0.23 -0.10 -0.56 -0.28 -0.05 -0.01
Income tax expense 0.10 0.02 0.01 0.00 0.05 -0.03 0.01 0.01 -0.01 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net income 0.30 -0.27 -0.11 -0.22 -0.21 0.17 -0.23 -0.23 -0.15 5.10 -0.30 -0.29 -0.03 -0.35 -0.32 -0.35 -0.29 -0.28 -0.21 -0.08 -0.51 -0.26 -0.04 0.00
about 2 months ago
Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19
Total cash and short-term investments + 4.30 4.89 6.54 1.68 2.07 2.21 2.19 0.85
Accounts receivable, net 0.79 0.08 0.04 0.01 0.01 0.02 0.01
Inventories 0.04 0.00 -0.02 0.06 0.00
Other current assets 0.08 0.11 0.07 0.08 0.08 0.04 0.02 0.32
Total current assets 5.17 5.00 6.73 1.80 2.15 2.19 2.22 1.19
Total non-current assets + 0.56 0.44 0.49 0.59 0.44 0.50 0.26 0.20
Total assets 5.73 5.44 7.22 2.39 2.59 2.69 2.48 1.39
Total current liabilities + 0.28 0.15 0.27 0.27 0.18 0.22 0.09 0.21
Total non-current liabilities + 0.15 0.10 0.51 0.51 0.34 0.31 0.28 0.24
Total liabilities 0.44 0.25 0.77 0.78 0.52 0.53 0.37 0.45
Total stockholders' equity + 4.53 4.69 5.97 1.16 1.66 1.90 2.03 0.94
Common shares outstanding 694 725 831 713 670 685 685 215
Show Quarterly Balance Sheet
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20
Total cash and short-term investments + 4.30 4.53 4.39 4.50 4.89 5.15 5.39 5.39 6.54 6.68 1.42 1.43 1.70 1.55 1.60 1.94 2.07 2.23 2.50 2.00 2.06 0.00 0.00 0.00 0.00
Accounts receivable, net 0.79 0.14 0.02 0.02 0.08 0.06 0.05 0.04 0.03 0.03 0.03 0.01 0.01 0.01 0.01 0.01 0.02
Inventories -0.19 0.03 0.04 0.01 0.00 0.00 0.00 0.06 0.07 -0.02 0.05 0.04 0.05
Other current assets 0.08 0.13 0.13 0.11 0.11 0.07 0.39 0.39 0.07 0.07 0.08 0.08 0.08 0.09 0.01 0.09 0.08 0.01 0.00 0.01 0.05 0.00
Total current assets 5.17 4.66 4.51 4.62 5.00 5.36 5.80 5.80 6.73 6.81 1.55 1.56 1.80 1.65 1.71 2.04 2.15 2.29 2.56 2.06 2.19 2.22
Total non-current assets + 0.56 0.57 0.55 0.42 0.44 0.43 0.40 0.40 0.49 0.51 0.51 0.58 0.59 0.56 0.50 0.56 0.44 0.51 0.55 0.40 0.40
Total assets 5.73 5.23 5.06 5.03 5.44 5.79 6.21 6.21 7.22 7.31 2.07 2.14 2.39 2.20 2.22 2.60 2.59 2.80 3.10 2.45 2.59
Total current liabilities + 0.28 0.15 0.13 0.11 0.15 0.14 0.56 0.56 0.27 0.24 0.27 0.25 0.27 0.24 0.23 0.33 0.18 0.16 0.30 0.21 0.22 0.09
Total non-current liabilities + 0.15 0.10 0.12 0.10 0.10 0.11 0.07 0.07 0.51 0.48 0.47 0.56 0.51 0.53 0.47 0.49 0.34 0.37 0.35 0.27 0.31
Total liabilities 0.44 0.25 0.26 0.22 0.25 0.26 0.63 0.63 0.77 0.73 0.74 0.80 0.78 0.78 0.70 0.82 0.55 0.55 0.65 0.47 0.53
Total stockholders' equity + 4.53 4.27 4.36 4.35 4.69 5.19 5.15 5.15 5.97 6.09 0.95 0.91 1.16 0.96 1.16 1.38 2.04 2.25 2.04 1.72 1.80
Common shares outstanding 812 697 681 680 707 723 735 735 803 844 770 759 743 713 700 696 693 687 685 685 685 685 685 685
about 2 months ago
Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19
Operating cash flow + -0.75 -0.84 -0.77 -0.84 -0.68 -0.55 -0.76 -1.02
Cash flow from investing + -0.68 -1.77 5.20 -0.04 0.30 -0.03 1.69 -0.06
Cash flow from financing + 0.13 -1.22 0.42 0.50 0.31 0.46 0.22 0.77
Change in cash -1.30 -3.83 4.86 -0.39 -0.07 -0.13 1.15 -0.31
Show Quarterly Cash Flow
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20
Operating cash flow + -0.16 -0.20 -0.19 -0.20 -0.17 -0.21 -0.27 -0.27 -0.11 -0.21 -0.20 -0.25 -0.18 -0.22 -0.19 -0.25 -0.15 -0.27 -0.12 -0.14 -0.11 -0.24 -0.10 -0.11 -0.09
Cash flow from investing + 0.13 0.15 0.12 -1.09 1.07 0.45 -3.29 -3.29 0.01 5.23 -0.04 0.00 0.11 0.00 -0.15 -0.01 -0.01 -0.01 0.32 0.00 0.00 0.00 -0.03 -0.05
Cash flow from financing + -0.03 0.29 0.06 -0.19 -0.18 -0.27 -0.11 -0.11 -0.03 0.24 0.21 0.01 0.21 0.15 -0.01 0.14 0.00 -0.01 0.30 0.01 0.10 0.00 0.18 0.18 -1.10
Change in cash -0.06 0.24 0.00 -1.48 0.72 -0.03 -3.67 -3.67 -0.13 5.26 -0.03 -0.24 0.14 -0.07 -0.34 -0.12 -0.15 -0.28 0.50 -0.13 -0.01 -0.24 0.08 0.04 -1.23
about 2 months ago

Roivant Sciences Ltd. (ROIV) - Long Term Investments

1Y 2Y 5Y Max
about 2 months ago

Roivant Sciences Ltd. (ROIV) - Total Non Current Assets

1Y 2Y 5Y Max
about 2 months ago

Roivant Sciences Ltd. (ROIV) - Current Net Receivables

1Y 2Y 5Y Max
about 2 months ago

Roivant Sciences Ltd. (ROIV) - Cash And Short Term Investments

1Y 2Y 5Y Max
about 2 months ago

Roivant Sciences Ltd. (ROIV) - Cash And Cash Equivalents At Carrying Value

1Y 2Y 5Y Max
about 2 months ago

Roivant Sciences Ltd. (ROIV) - Total Current Assets

1Y 2Y 5Y Max
about 2 months ago

Roivant Sciences Ltd. (ROIV) - Total Assets

1Y 2Y 5Y Max
about 2 months ago

Roivant Sciences Ltd. (ROIV) - Property Plant Equipment

1Y 2Y 5Y Max
about 2 months ago

Roivant Sciences Ltd. (ROIV) - Current Long Term Debt

1Y 2Y 5Y Max
about 2 months ago

Roivant Sciences Ltd. (ROIV) - Long Term Debt

1Y 2Y 5Y Max
about 2 months ago